IHS Chemical Week

People & Business :: Companies

Pfizer Gets Approval from European Commission for $68-Billion Wyeth Acquisition

2:10 AM MDT | July 20, 2009 | Deepti Ramesh

Pfizer says that the European Commission, under the European Union Merger Regulation, has approved Pfizer’s previously announced acquisition of Wyeth for a total of $68 billion. Pfizer agreed to acquire Wyeth in January 2009 in a deal that the companies say will create one of the most diversified health care firms worldwide. The merged company would offer a broad product portfolio including 17 products with more than $1 billion/year each in revenue. No drug is expected to account for more than 10% of the combined entity’s revenue in...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa